PDB59 - COST-EFFECTIVENESS OF SWITCHING TO INSULIN DEGLUDEC (IDEG) U100 FROM CURRENTLY AVAILABLE BASAL INSULINS IN BELGIUM BASED ON EVIDENCE FROM REAL-WORLD CLINICAL PRACTICE
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.764
https://www.valueinhealthjournal.com/article/S1098-3015(18)34064-6/fulltext
Title :
PDB59 - COST-EFFECTIVENESS OF SWITCHING TO INSULIN DEGLUDEC (IDEG) U100 FROM CURRENTLY AVAILABLE BASAL INSULINS IN BELGIUM BASED ON EVIDENCE FROM REAL-WORLD CLINICAL PRACTICE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34064-6&doi=10.1016/j.jval.2018.09.764
First page :
Section Title :
Open access? :
No
Section Order :
166